Tampa General Hospital's ECMO-specific infection prevention protocol eradicated bloodstream infections, reducing rates from 36% to 0%, demonstrating the effectiveness of tailored infection control measures in high-risk patients.
Tampa General Hospital (TGH), a leading tertiary care academic medical center, has successfully eradicated bloodstream infections (BSIs) in patients undergoing extracorporeal membrane oxygenation (ECMO) within their 18-bed cardiothoracic intensive care unit (CTICU).
This achievement was showcased in a presentation titled “Bundled Approach to Reduce Bloodstream Infections in Patients Requiring Use of Extracorporeal Membrane Oxygenation” at the 2024 Association for Professionals in Infection Control and Epidemiology (APIC) Annual Conference & Exposition in San Antonio, Texas, held from June 3 to 5. There, TGH representatives reported a reduction in ECMO-related BSI rates from 36% in October 2021 to 0% in April 2022. This zero-infection rate was sustained for 7 months, with the hospital maintaining a 4-month streak of no infections.
To find out how that reduction was accomplished, Infection Control Today® (ICT®) spoke with the authors of the study, all of whom work for Tampa General Hospital: Mini Radhakrishnan, BSN, RN, CIC, the infection preventionist, and Kimberly E. Atrubin, MPH, CIC, CPHQ, FAPIC, the infection prevention director. The other authors were Carmen M. Murphy, MSN, RN, CIC, FAPIC, the infection prevention manager, and Lauren Wojciechowski, DNP, AGACNP-BC, nurse practitioner.
“When we did our literature review, we did find that there was no standardized protocol underlying care of ECMO patients,” Radhakrishnan told ICT. “There were protocols in place somewhat aligned to central line bloodstream infection, but they did not customize to the patient's need. In our facility during the [COVID-19] era, we noticed a high spike in bloodstream infections; it rose to about 36% in October [2021].”
The team did a literature review to focus on ECMO patients and the bloodstream infections they get. “We found so many environmental clinical risk factors underlining patients,” Radhakrishnan explained. “So, amalgamating all that and the patient's risk factors, we came up with a management approach to reduce ECMO. And that is my presentation today.”
The authors emphasized that they did not reach their goal of no infections without teamwork. “Really big kudos to [Radhakrishnan] for even identifying the fact that we had several bloodstream infections,” Atrubin said. “And to even go down this pathway because it's not a traditional element of surveillance. So, it's not something that we have to report nationally through the National Healthcare Safety Network (NHSN). So, this could easily be something that gets lost in routine infection prevention departments. So, for her even identifying that this was an issue in our unit, and then having to kind of work through that process [of] working with the team and collaborating with them, and coming up with a tool that would help us improve [the issue] was outstanding work.”
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.